Cough & Cold Medicine Manufacturing OTC
Fewer individuals are visiting their healthcare providers for their flu and cough, causing industry revenue to grow due to many healthcare providers recommending that their patients use OTC drugs to address their minor health ailments. The rise in the number of time-strapped consumers has also propped up demand for OTC drugs, especially during cold and flu season, bolstering industry revenue. Over the five years to 2021, industry revenue is forecast to continue growing, due to rising demand for cough and cold medication from immunosuppressed individuals, such as the elderly population. However, the industry will also contend with rising external competition from private-label products sold in drug stores.
This industry manufactures over-the-counter (OTC) cough and cold treatments and suppressants. Products include systemic remedies like antihistamines and combination products, decongestants and medicated candies. The industry does not include companies that are primarily retailers, like pharmacies or department stores.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.